Rosiglitazone decreases blood pressure and renal injury in a female mouse model of systemic lupus erythematosus

Women with systemic lupus erythematosus (SLE) exhibit a high prevalence of hypertension and renal injury. Rosiglitazone (Rosi), a peroxisome proliferator activator receptor gamma (PPARγ) agonist, has renal protective and antihypertensive effects. We tested whether Rosi ameliorates hypertension and r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Venegas-Pont, Marcia, Sartori-Valinotti, Julio C., Maric, Christine, Racusen, Lorraine C., Glover, Porter H., McLemore, Gerald R., Jones, Allison V., Reckelhoff, Jane F., Ryan, Michael J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Physiological Society 2009
Assuntos:
Water and Electrolyte Homeostasis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2698614/
https://ncbi.nlm.nih.gov/pubmed/19193937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpregu.90992.2008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados